Original Research
Published on 13 Apr 2023
KLF2 is a clinical diagnostic and treatment biomarker of breast cancer
in Cell Death and Survival
- 7,031 views
- 11 citations
Original Research
Published on 13 Apr 2023
in Cell Death and Survival
Original Research
Published on 02 Feb 2021
in Cellular Biochemistry
Original Research
Published on 18 Nov 2022
in Primary Immunodeficiencies
Original Research
Published on 08 Nov 2022
in Molecular and Cellular Pathology
Original Research
Published on 08 Jun 2023
in Cellular Biochemistry
Original Research
Published on 19 Sep 2023
in Alloimmunity and Transplantation
Original Research
Published on 30 Nov 2022
in Inflammation
Perspective
Published on 17 May 2021
in Atherosclerosis and Vascular Medicine
Original Research
Published on 21 Jan 2025
in Hematologic Malignancies
Original Research
Published on 20 May 2021
in Cancer Genetics
Review
Published on 13 May 2020
in Autoimmune and Autoinflammatory Disorders
Original Research
Published on 31 May 2023
in Molecular Diagnostics and Therapeutics
Review
Published on 12 May 2023
in Immunological Tolerance and Regulation
Original Research
Published on 18 Feb 2026
in Cancer Immunity and Immunotherapy
Review
Accepted on 03 Apr 2026
in Epigenomics and Epigenetics
Original Research
Published on 28 Apr 2022
in Immunological Tolerance and Regulation